Rebecca Byam is CFO at HCW Biologics Inc. (HCWB). They have made 19 open-market trades across 1 company since 2021, most recently 2026-05-22.
CIK 0001866256
19 open-market purchases totalling $1.7M since 2021, never a sale. Across 19 scored buys the stock is down 18.2% at ninety days, and 21.9 points behind the S&P over the same stretch.
19 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| HCWB | 18,466 | $23K |
Shares reported on the most recent Form 4, priced at the 2026-05-27 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 37% | 32% | 21% |
| Avg Move | +0.3% | -5.1% | -18.2% |
| Alpha | +0.9% | -3.4% | -21.9% |
| Scored | 19 | 19 | 19 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HCWB | BUY | 2026-05-22 | 2026-05-27 | $1.41 | $20K | -37.6% | -53.1% | +11.6% |
| HCWB | BUY | 2025-05-08 | 2025-05-09 | $26.00 | $220K | +37.7% | -11.7% | -28.6% |
| HCWB | BUY | 2023-09-13 | 2023-09-15 | $2.10 | $11K | -4.9% | -11.2% | -44.7% |
| HCWB | BUY | 2023-09-11 | 2023-09-13 | $2.07 | $21K | -1.5% | -9.0% | -45.0% |
| HCWB | BUY | 2023-09-07 | 2023-09-08 | $1.99 | $20K | +2.0% | -2.0% | -46.1% |
| HCWB | BUY | 2023-09-06 | 2023-09-07 | $1.95 | $10K | +13.3% | +6.4% | -41.5% |
| HCWB | BUY | 2023-06-09 | 2023-06-09 | $2.06 | $41K | -1.4% | +5.8% | -5.8% |
| HCWB | BUY | 2023-06-07 | 2023-06-08 | $2.06 | $51K | -2.4% | +4.8% | -9.6% |
| HCWB | BUY | 2023-06-05 | 2023-06-07 | $1.74 | $68K | -5.0% | +4.1% | -11.4% |
| HCWB | BUY | 2023-05-25 | 2023-05-31 | $1.64 | $66K | +41.6% | +45.6% | +27.5% |
| HCWB | BUY | 2023-05-22 | 2023-05-24 | $1.55 | $142K | +12.8% | +40.2% | +18.9% |
| HCWB | BUY | 2022-09-14 | 2022-09-15 | $2.58 | $39K | -2.4% | -7.3% | -15.3% |
| HCWB | BUY | 2022-09-12 | 2022-09-14 | $2.62 | $78K | -4.8% | -11.5% | -23.5% |
| HCWB | BUY | 2022-08-30 | 2022-09-01 | $2.56 | $44K | +1.2% | -6.5% | -14.5% |
| HCWB | BUY | 2022-08-26 | 2022-08-30 | $2.56 | $51K | +0.0% | -9.6% | -18.0% |
| HCWB | BUY | 2022-08-24 | 2022-08-26 | $2.54 | $229K | +2.3% | -7.7% | -12.3% |
| HCWB | BUY | 2022-06-13 | 2022-06-15 | $2.44 | $305K | -10.9% | -5.0% | +7.5% |
| HCWB | BUY | 2021-08-19 | 2021-09-10 | $4.40 | $44K | -27.1% | -40.5% | -43.5% |
| HCWB | BUY | 2021-07-22 | 2021-07-23 | $8.00 | $200K | -7.2% | -28.1% | -50.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.